StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
June 1, 2026 6:54 AM
Piper Sandler analyst Jessica Tassan reiterated an Overweight rating and $113.00 price target on CVS Health (NYSE: CVS).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
